EDGAR Filing Documents for 0001104659-23-080765

Form 8-K - Current report:

SEC Accession No. 0001104659-23-080765

Filing Date

2023-07-13

Accepted

2023-07-13 16:41:57

Documents

Period of Report

2023-07-13

Items

Item 1.01: Entry into a Material Definitive Agreement
Item 3.02: Unregistered Sales of Equity Securities
Item 5.03: Amendments to Articles of Incorporation or Bylaws; Change in Fiscal Year
Item 8.01: Other Events
Item 9.01: Financial Statements and Exhibits

Interactive Data

Document Format Files

Seq	Description	Document	Type	Size
1	FORM 8-K	tm2321191d1_8k.htm iXBRL	8-K	43134
2	EXHIBIT 3.1	tm2321191d1_ex3-1.htm	EX-3.1	308177
3	EXHIBIT 4.1	tm2321191d1_ex4-1.htm	EX-4.1	191807
4	EXHIBIT 10.1	tm2321191d1_ex10-1.htm	EX-10.1	334462
5	EXHIBIT 10.2	tm2321191d1_ex10-2.htm	EX-10.2	175520
6	EXHIBIT 99.1	tm2321191d1_ex99-1.htm	EX-99.1	37767
	Complete submission text file	0001104659-23-080765.txt		1531782

Data Files

Seq	Description	Document	Type	Size
7	XBRL TAXONOMY EXTENSION SCHEMA	ptpi-20230713.xsd	EX-101.SCH	3027
8	XBRL TAXONOMY EXTENSION LABEL LINKBASE	ptpi-20230713_lab.xml	EX-101.LAB	34240
9	XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE	ptpi-20230713_pre.xml	EX-101.PRE	22367
11	EXTRACTED XBRL INSTANCE DOCUMENT	tm2321191d1_8k_htm.xml	XML	3529

Mailing Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036

Business Address 1185 AVENUE OF THE AMERICAS, 3RD FLOOR NEW YORK NY 10036 973-242-0005

Petros Pharmaceuticals, Inc. (Filer) CIK: 0001815903 (see all company filings)